Michael Wilkinson

Title(s)Assistant Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Drexel University College of Medicine, Philadelphia, PAMD05/2011Medicine
    University of Chicago, Chicago, IL06/2014Internal Medicine Residency
    University of California San Diego, San Diego, CA06/2018Cardiovascular Medicine Fellowship

    Collapse Research 
    Collapse Research Activities and Funding
    Effect of time-restricted eating on catecholamine-sensitivity of adipose tissue in obese adults
    NIH/NCATS 2KL2TR001444-06Feb 1, 2021 - Jan 31, 2024
    Role: Principal Investigator
    Impact of time-restricted feeding (TRF) on glucose homeostasis and mitochondrial function in patients with metabolic syndrome
    NIH/NIDDK 1R01DK118278-01Jul 1, 2018 - Jun 30, 2023
    Role: Co-investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024 Mar 29. Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM. PMID: 38565461.
      View in: PubMed   Mentions:    Fields:    
    2. Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. J Am Heart Assoc. 2024 Mar 08; e032031. Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR. PMID: 38456415.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Time-Restricted Eating: A Novel Dietary Strategy for Cardiac Rehabilitation. Can J Cardiol. 2023 11; 39(11S):S384-S394. Small S, Iglesies-Grau J, Gariepy C, Wilkinson M, Taub P, Kirkham A. PMID: 37734709.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes. Curr Cardiol Rep. 2023 Oct; 25(10):1175-1187. Ma GS, Chiou TT, Wilkinson MJ. PMID: 37632608; PMCID: PMC10651710.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. J Am Heart Assoc. 2023 06 06; 12(11):e028892. Wilkinson MJ, Lepor NE, Michos ED. PMID: 37260036; PMCID: PMC10381990.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease. Am J Prev Cardiol. 2023 Mar; 13:100473. Wilkinson MJ, Xu I, Vasudevan RS, You H, Xu R, Taub PR. PMID: 36865903; PMCID: PMC9971059.
      View in: PubMed   Mentions:
    7. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022 11 01; 132(21). Tamaki N, Ahlholm N, Luukkonen PK, Porthan K, Sharpton SR, Ajmera V, Kono Y, Dave S, Ahmed A, Sundaram V, Wilkinson MJ, Patton H, Gupta H, Cervantes V, Hernandez C, Lopez SJ, Loomba R, Baumgartner A, Richards L, Arkkila PE, Nemes K, Isoniemi H, Yki-Järvinen H, Loomba R. PMID: 36317632; PMCID: PMC9621132.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    8. Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic. J Clin Lipidol. 2023 Jan-Feb; 17(1):73-77. Chiou TT, Tomasi K, Taub PR, Wilkinson MJ. PMID: 36371372.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13; 11(20). Bhatia HS, Wilkinson MJ. PMID: 36294361; PMCID: PMC9604626.
      View in: PubMed   Mentions: 8  
    10. Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis. Atherosclerosis. 2022 05; 349:144-150. Bhatia HS, Ma GS, Taleb A, Wilkinson M, Kahn AM, Cotter B, Yeang C, DeMaria AN, Patel MP, Mahmud E, Reeves RR, Tsimikas S. PMID: 35144769; PMCID: PMC9674369.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship. Am J Cardiol. 2019 12 15; 124 Suppl 1:S3-S11. Wilkinson MJ, Zadourian A, Taub PR. PMID: 31741438.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    12. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab. 2020 01 07; 31(1):92-104.e5. Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR. PMID: 31813824; PMCID: PMC6953486.
      View in: PubMed   Mentions: 276     Fields:    Translation:HumansCTClinical Trials
    13. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement. Angiology. 2019 Apr; 70(4):332-336. Ma GS, Wilkinson MJ, Reeves RR, Yeang C, DeMaria AN, Cotter B, Patel M, Mahmud E, Tsimikas S. PMID: 30700108.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    14. Inappropriate ICD Shock From Perceived Ventricular Fibrillation During Balloon Manipulation at the Time of Percutaneous Coronary Intervention. J Invasive Cardiol. 2017 Aug; 29(8):E94-E95. Pourdjabbar A, Wilkinson MJ, Ang L, Reeves RR, Mahmud E, Patel MP. PMID: 28756425.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting. Angiology. 2017 Oct; 68(9):795-798. Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B. PMID: 28068801.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Curr Opin Cardiol. 2016 07; 31(4):440-50. Yeang C, Wilkinson MJ, Tsimikas S. PMID: 27205885; PMCID: PMC4956483.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    17. Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice. Rev Cardiovasc Med. 2014; 15(1):1-10. Toth PP, Shah PK, Wilkinson MJ, Davidson MH, McCullough PA. PMID: 24762461.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans